A high expression of CYP2W1 in tumor tissue, particularly in breast cancer (overexpression ~230-fold) in comparison to normal mammary gland tissues [33], makes this CYP isoform an attractive anticancer drug target. Here, CYP2W1 is linked to breast carcinoma.